SKILARENCE cpr 120 mg 90 pce

7680667030027 CH-66703 L04AX07 10.03.0.
SKILARENCE cpr 120 mg 90 pce
SKILARENCE cpr 120 mg 90 pce
SKILARENCE cpr 120 mg 90 pce
1 / 3
google

Details

Product number
6670302
CPT
-
Packaging group
90
Unit
Tablette(n)
Composition
dimethylis fumaras 120 mg, lactosum monohydricum 144 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas, polysorbatum 80, talcum, triethylis citras, simeticonum, E 132, E 171, natrii hydroxidum, pro compresso obducto corresp. natrium 1.94 mg.

Articles (1)

Skilarence 120mg, magensaftresistente Tablette
Tablette
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/10/2024
Patient information leaflet
Français
16/10/2024
Patient information leaflet
Italien
16/10/2024
Professional SmPC
Allemand
16/10/2024
Professional SmPC
Français
16/10/2024
Professional SmPC
Italien
16/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
120.0 MG Substance Wirkstoff (Principe actif)
(N/A)
144.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
1.94 MG Substance HBESI

Authorization holder

Almirall AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
66703
Drug name
Skilarence, magensaftresistente Tablette
Galenic form
MATB
ATC Code
L04AX07
Authorization status
Z
Dispensation category
B
First authorization
28/01/2019
Authorization expiration date
31/12/9999
IT number
10.03.0.
Domain
Human medicine
Field of application
Behandlung von Hautmanifestationen bei Patienten mit mittelschwerer bis schwerer Plaque-Psoriasis

Packaging details

Description (FR)
SKILARENCE cpr 120 mg 90 pce
Description (DE)
SKILARENCE Tabl 120 mg 90 Stk
Market launch
28/01/2019
Narcotic (BTM)
No

Available generics

Dimethylfumarat Accord, magensaftresistente Hartkapseln
GTIN: 7680694660013
CHF 101.60
View
Dimethylfumarat Accord, magensaftresistente Hartkapseln
GTIN: 7680694660020
CHF 357.05
View
Dimethylfumarat Accord, magensaftresistente Hartkapseln
GTIN: 7680694660037
CHF 1038.40
View
Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
GTIN: 7680695040012
CHF 113.05
View
Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
GTIN: 7680695040029
CHF 403.05
View
Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
GTIN: 7680695040036
CHF 1176.35
View
Dimethylfumarat Sandoz, magensaftresistente Hartkapseln
GTIN: 7680692030016
CHF 113.05
View
Dimethylfumarat Sandoz, magensaftresistente Hartkapseln
GTIN: 7680692030023
CHF 403.05
View
Dimethylfumarat Sandoz, magensaftresistente Hartkapseln
GTIN: 7680692030030
CHF 1176.35
View
Dimethylfumarat Viatris, magensaftresistente Hartkapseln
GTIN: 7680694110013
CHF 113.05
View

Other packaging sizes

SKILARENCE cpr 30 mg 42 pce
42 TABL
GTIN: 7680667030010
View
SKILARENCE cpr 120 mg 180 pce
180 TABL
GTIN: 7680667030034
View